Tuesday, 18 Jun 2019

View Our Coverage from EULAR 2019 in Madrid

TODAY'S HEADLINES

EULAR 2019- Day 4 Report

Saturday June 15th was the last half-day at EULAR 2019 but was highlighted by the “late-breaking” (LB) presentations that were presented from the podium and by poster.

Below are the top “LB” presentations from EULAR this year:

Understanding Non-arthritic Rheumatic iRAEs

A better understanding of rheumatic immune-related adverse event phenotypes beyond inflammatory arthritis has been furthered by work from three abstracts presented at EULAR 2019 in Madrid.

Blinded by the Use of Antimalarials in Lupus?

Hydroxychloroquine (HCQ) will decrease SLE flares improve lipids, decrease clots, improve survival, augment the response to mycophenolate and are the cornerstone of treatment as per the SLE EULAR guidelines presented at EULAR 2019 in Madrid and also published in ARD. But, if you prescribe them long term, will your patients go blind?

Ultrasound Reveals Which Anti-CCP Positive Patients Progress to Arthritis 

Power Doppler signal on baseline ultrasound exam may well help stratify anti-CCP positive patients with musculoskeletal symptoms but no clinical synovitis, according to data from the Leeds Institute of Rheumatic and Musculoskeletal Medicine presented at EULAR 2019.

EULAR 2019 – Day 3 Report

The third day of EULAR 2019 started with novel biologics, the efficacy of secukinumab in axial psoriatic arthritis, neurologic events with TNF inhibitors from the DANBIO database (OP0261), and neuropathy in SLE (OP0252), but above all this was a big poster day. Here are selected highlights from day 3 EULAR in Madrid.

Sponsored by Sandoz, Inc.
A first-of-its kind educational video series focusing on the “hot topics” in biosimilars from the perspective of leading Rheumatology experts. This educational series is presented by Sandoz, Inc.
BLOG
This is probably the most difficult question that a physician is confronted with. A patient is stricken with a new disease or problem and before it even sinks in or is fully comprehended, the patient wants to know “why” or “how” long before they want to know what are we can do about it.

Nearly half of all available vacation days go unused and over 40% of Americans failed to use any vacation days in 2015. Common sense says that taking more time off (not less) is likely to lead to increased work productivity. Your next vacation is essential to building a better you. Here are some tips to insure you get the most from your time off.

“If you don't know what you want, you end up with a lot you don't.” ― Chuck Palahniuk, "Fight

He would have died. About 4 weeks ago, my 74 year old father-in-law, “Pops” was admitted to a small community hospital for delirium and worsening congestive heart failure. He was seen by a caring hospitalist and a local cardiologist who was deemed good by all the locals, but they could not get him better. Despite the delirium, Pops pleaded he wanted to live to see my 8 year old son graduate high school. My husband, who is an internist, respected the other doctors’ decision and did not want to interfere with his dad’s medical care. With tears in his eyes, he whispered, “I wish we could do more.” My heart was heavy as I did not want to go against my in-law’s wishes to get a second opinion. Trying to make the right decision, I talked to my colleagues, I talked to my patients, and I talked to my own family: what should I do? Go against my in-law’s wishes and transfer him to Dallas for a full evaluation or be complicit in the Do Not Resuscitate Order?
RheumNow Live Preview with Dr. Michael Holers (Insights into Preclinical RA)
/vef/load/c5e8bb87fc3ff0231f9e5f84922ef44f?width=640&height=365

Access RNL On Demand
Register/Login at RheumNow Live On Demand for all the archived content from the 2019 meeting

Daily Download

FDA Reviews Febuxostat CV Safety